Document Detail


Development and Psychometric validation of the Diabetes Therapy-Related QOL (DTR-QOL) Questionnaire.
MedLine Citation:
PMID:  22313327     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Objective: We developed and evaluated the psychometric properties of the Diabetes Therapy-Related QOL (DTR-QOL) as a disease-specific, self-administered questionnaire to assess the influence of diabetes treatment on patient QOL, regardless of treatment method. Methods: This new questionnaire was developed and validated in a standardized manner: Item development, pilot-testing and psychometric validation. A survey was conducted using the provisional version of the questionnaire, and reliability and validity were evaluated with psychometric testing. Results: The provisional version of the questionnaire was generated with 29 items through literature review and pilot testing. For psychometric assessment, analyses were performed on the responses of 284 adult Japanese patients with diabetes. Factor analysis by the principal factor method with promax rotation revealed 4 factors; "burden on social activities and daily activities" (13 items), "anxiety and dissatisfaction with treatment" (8 items), "hypoglycemia" (4 items), and "satisfaction with treatment" (4 items). For reliability, the intraclass correlation was 0.87, and Cronbach's alpha coefficient was 0.94, indicating adequate test-retest reliability and internal consistency. For known-group validity, there were significant differences in scores for following variables: age, diabetes type, HbA1c, treatment method, glycemic control, hypoglycemia, nocturnal hypoglycemia, concern about weight gain, health status (patient assessment), and degree of communication with physician. Conclusions: The DTR-QOL, with good reliability and validity, can assess the influence of diabetes treatment on patient QOL. The DTR-QOL can be used regardless of treatment method that patients receive, and this characteristic enables to detect a difference on patients QOL between treatment methods before and after a switch of treatment. Limitations of this study include representativeness of the patient sample. The relatively small number of patients with type 1 diabetes should be noted. Also, responsiveness of the DTR-QOL has not yet been examined.
Authors:
Hitoshi Ishii
Related Documents :
19032037 - Visceral fat and adiponectin: associations with insulin resistance are tissue-specific ...
22498767 - Ezetimibe ameliorates early diabetic nephropathy in db/db mice.
2879757 - Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output i...
22495327 - Intravitreal injection of ranibizumab during cataract surgery in patients with diabetic...
2311437 - Risk factors in continuous ambulatory peritoneal dialysis. a seven year follow up.
18722777 - Derivatives of 1,4-bis(3-hydroxycarbonyl-4-hydroxyl)styrylbenzene as ptp1b inhibitors w...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-8
Journal Detail:
Title:  Journal of medical economics     Volume:  -     ISSN:  1941-837X     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9892255     Medline TA:  J Med Econ     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Economic evaluation of tocilizumab combination in the treatment of moderate to severe rheumatoid art...
Next Document:  COST-EFFECTIVENESS OF CINACALCET IN SECONDARY HYPERPARATHYROIDISM IN THE UNITED STATES.